Long-term view

Professor John Wilding discusses how a patient he’s seen over many years shaped his view of type 2 diabetes and the importance of fully utilising medications and technologies.

‌

For more from Professor Wilding, enrol on the EASD e-Learning course ‘SGLT-2 inhibitors’.